Champions Oncology, Inc. Q2 FY2022 Earnings Call

Champions Oncology, Inc. (CSBR)

Earnings Call FY2022 Q2 Call date: 2021-12-13 Concluded

Quarter scorecard

Revenue

$11.79M

+16.5% YoY

Diluted EPS

$0.02

Net income

$277,000

+27600% YoY

Pharmacology Services $11.14M

+11%

Product And Service Other $643,000

+1548.7%

Personalized Oncology Services $0

-100%